ZCA
NVO

Zeke Capital Advisors’s Novo Nordisk NVO Stock Holding History

Zeke Capital Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.05M Sell
30,254
-3,140
-9% -$184K 0.13% 70
2022
Q3 		$1.66M Hold
33,394
– – 0.12% 84
2022
Q2 		$1.86M Buy
33,394
+3,930
+13% +$218K 0.12% 83
2022
Q1 		$1.64M Buy
29,464
+2,436
+9% +$125K 0.08% 102
2021
Q4 		$1.51M Buy
27,028
+1,470
+6% +$79.6K 0.09% 74
2021
Q3 		$1.23M Hold
25,558
– – 0.07% 86
2021
Q2 		$1.07M Buy
25,558
+1,894
+8% +$73.4K 0.07% 93
2021
Q1 		$798K Sell
23,664
-1,260
-5% -$44.9K 0.06% 101
2020
Q4 		$870K Buy
24,924
+5,164
+26% +$178K 0.07% 90
2020
Q3 		$686K Buy
19,760
+46
+0.2% +$1.53K 0.08% 83
2020
Q2 		$645K Sell
19,714
-35,348
-64% -$1.13M 0.12% 81
2020
Q1 		$1.66M Sell
55,062
-18,782
-25% -$559K 0.47% 28
2019
Q4 		$2.14M Sell
73,844
-116
-0.2% -$3.21K 0.18% 106
2019
Q3 		$1.91M Buy
73,960
+1,134
+2% +$28.7K 0.17% 103
2019
Q2 		$1.86M Buy
72,826
+2,652
+4% +$65.5K 0.18% 103
2019
Q1 		$1.83M Buy
70,174
+6,308
+10% +$155K 0.17% 105
2018
Q4 		$1.47M Sell
63,866
-193,652
-75% -$4.3M 0.14% 131
2018
Q3 		$6.07M Buy
257,518
+6,986
+3% +$170K 0.5% 39
2018
Q2 		$5.78M Buy
+250,532
New +$5.95M 0.54% 40

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Zeke Capital Advisors's NVO Position: Q4 2022 in Review

Zeke Capital Advisors reduced its Novo Nordisk (NVO) stake by 9.4% in Q4 2022, selling an estimated $184K and leaving 30,254 shares worth $2.05M. The position accounts for 0.13% of the portfolio, ranked #70.

Zeke Capital Advisors first reported a position in NVO in Q2 2018 and has held it in 19 quarters since. The position peaked at $6.07M in Q3 2018. 1,049 funds tracked by Wall St. Rank hold NVO as of Q4 2022.

  • Zeke Capital Advisors held 30,254 shares of Novo Nordisk worth $2.05M as of Q4 2022.
  • Zeke Capital Advisors sold 3,140 Novo Nordisk shares in Q4 2022, an estimated $184K.
  • Novo Nordisk made up 0.13% of Zeke Capital Advisors's portfolio in Q4 2022, its #70 holding.
  • Zeke Capital Advisors first reported a position in Novo Nordisk in Q2 2018 and has held it in 19 quarters since.
  • Zeke Capital Advisors's Novo Nordisk position peaked at $6.07M in Q3 2018.
  • 1,049 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2022.

Based on Zeke Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.